JUSTIFICATION OF RESTRICTIONS OF A STANDARD APPROACH TO PHLEBOSTEROTHERAPY IN VARICANOUS EXPANSION OF THE VEINS OF THE LOWER LIMBS OF THE LARGE SIZES

Abstract: the analysis of the frequency of infiltrates after a standard format of phlebosclerotherapy in 89 patients with varicose veins of the lower extremities, depending on the size of varicose veins, was carried out. All patients / clients considered in this report gave written informed consent to participate in the study and signed a bilateral non-disclosure agreement. Criteria for analysis were the results of treatment of varicose veins, namely, the frequency of infiltrates during phlebosclerotherapy. As sclerosant, when performing phlebosclerotherapy, ethoxy sclerol was used with a concentration from 0.5-1.0% with a diameter of veins up to 0.5 cm; 0.5-1.5% with a vein diameter of 0.6-1.0 cm and 1.5-3.0% with a diameter of varicose veins more than 1.0 cm. Depending on the size of varicose veins, patients were divided into 3 groups. In group I, which included 32 patients with varicose veins not more than 0.5 cm in size, a retrospective analysis of the results of phlebosclerotherapy and the frequency of infiltrates after its implementation was conducted. Group II consisted of 36 patients with a diameter of varicose veins from 0.5 cm to 1.0 cm. In Group III, 23 patients underwent phleboscleotherapy with varicose veins larger than 1.0 cm. After performing phlebosclerotherapy, varicose veins developed in group I in 2 (6.3 ± 2.2%) patients, in group II – in 11 (30.6 ± 7.6%), in group III – in 18 (78.3 ± 8.6%). At the same time, in group I, the incidence of infiltrates after phlebosclerotherapy for varicose veins was significantly less than in group II (P <0.05) and in group III (P <0.05), and in group II it was significantly less than in group III (P < 0.05). This makes it possible to justify the limitation of standard phleboscaleotherapy with varicose veins not exceeding 0.5 cm. If we consider infiltration as the predicted stage of the normal course of the period after the introduction of the sclerosant into the vein and apply innovative technologies for its correction, we can reconsider approaches to phlebosclerotherapy. Keywords: varicose veins, phlebosclerotherapy, sclerosant, infiltrate, periphlebitis, cosmetic defect